(Dow Jones) -- Monsanto Co. has bought assets from a California-based company that uses microbes to improve crop production.
Monsanto also said that it made an equity investment in Synthetic Genomics Inc. and that the two companies reached a multiyear agricultural research agreement
The purchase of assets from Agradis, which Synthetic Genomics co-founded in 2011, includes the collection of microbes as well as the company's name. Terms of the deal weren't disclosed.
The assets build upon Monsanto's agricultural biological platform, called BioDirect, launched last year. Agricultural biologicals generally refer to seed or crop treatments derived from natural materials.
Agradis has ...